Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 124, Issue 5, 2017, Pages 804-813

  Lavery, J A ^a   Friedman, A M ^a   Keyes, K M ^b   Wright, J D ^a   Ananth, C V ^a,b  

^a Columbia University ^*  (United States)

^b NONE   (United States)

Author keywords

Age period cohort analysis; gestational diabetes; temporal trends

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; FEMALE; GESTATION PERIOD; HOSPITALIZATION; HUMAN; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SMOKING; OBSTETRIC DELIVERY; PREGNANCY DIABETES MELLITUS; PREVALENCE; RACE; STILLBIRTH; TREND STUDY; UNITED STATES; MIDDLE AGED; NEWBORN; PREGNANCY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STILLBIRTH; UNITED STATES; YOUNG ADULT;

EID: 84994565381     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.14236     Document Type: Article

References (41)

1. International Diabetes Federation. IDF Diabetes Atlas, 6th edn. New York: Springer, 2014.
2. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 2008;198:525 e1-5.
3. Kim C, Ferrara A. Gestational Diabetes During and After Pregnancy. London, UK: Springer, 2010.
4. Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol 2003;158:1148–53.
5. Diagnosis ECot, Mellitus CoD. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5–20.
6. Crane SS, Wojtowycz MA, Dye TD, Aubry RH, Artal R. Association between pre-pregnancy obesity and the risk of cesarean delivery. Obstet Gynecol 1997;89:213–16.
7. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001;75:221–8.
8. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861–5.
9. Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, et al. Association of maternal diabetes with autism in offspring. JAMA 2015;313:1425–34.
10. Freinkel NJJ. American Diabetes Association Workshop-Conference on gestational diabetes: summary and recommendations. Diabetes Care 1980;3:499–501.
11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–53.
12. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 2004;103:526–33.
13. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM screening program. Diabetes Care 2005;28:579–84.
14. National Hospital Discharge Survey, National Center for Health Statistics, Centers for Disease Control Prevention. National Hospital Discharge Survey: Annual summary: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics, 1997.
15. Carstensen BPM, Laara E, Hills M. Epi: A package for statistical analysis in epidemiology (R package version 2.0). 2012. [http://CRAN.R-project.org/package=Epi] (accessed 10 July 2014).
16. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 2013;347:f6564.
17. Keyes KM, Ananth CV. Age, period, and cohort effects in perinatal epidemiology: implications and considerations. Paediatr Perinat Epidemiol 2014;28:277–9.
18. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES). Boca Raton, FL: Inter-university Consortium for Political and Social Research (ICPSR), 2012.
19. Yang Y, Land K. Age-Period-Cohort Analysis: New Models, Methods and Empirical Applications, 1st edn. Boca Raton, FL: Chapman and Hall/CRC; 2013. pp. 191–230, 1-84.
20. Ananth CV, Vintzileos AM. Trends in cesarean delivery at preterm gestation and association with perinatal mortality. Am J Obstet Gynecol 2011;204:505 e1-8.
21. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl 2):S141–6.
22. Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, Gardella C, et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005;193:125–34.
23. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10:194–203.
24. Tsai IH, Chen CP, Sun FJ, Wu CH, Yeh SL. Associations of the pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in Taiwanese women. Asia Pac J Clin Nutr 2012;21:82–7.
25. Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM 2001;94:347–56.
26. Makgoba M, Savvidou MD, Steer PJ. An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG 2012;119:276–82.
27. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep 2003;52:1–113.
28. O'Sullivan JB, Mahan CM. Criteria for the Oral Glucose Tolerance Test in Pregnancy. Diabetes 1964;13:278–85.
29. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21(Suppl 2):B161–7.
30. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.
31. Hapo Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.
32. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001;98:525–38.
33. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.
34. Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17:275–83.
35. Bonomo M, Cetin I, Pisoni MP, Faden D, Mion E, Taricco E, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab 2004;30:237–44.
36. Brown R, Wijekoon JH, Fernando A, Johnstone ED, Heazell AE. Continuous objective recording of fetal heart rate and fetal movements could reliably identify fetal compromise, which could reduce stillbirth rates by facilitating timely management. Med Hypotheses 2014;83:410–17.
37. Chen HY, Chauhan SP, Ananth CV, Vintzileos AM, Abuhamad AZ. Electronic fetal heart rate monitoring and its relationship to neonatal and infant mortality in the United States. Am J Obstet Gynecol 2011;204:491. e1-10.
38. Ananth CV, Chauhan SP, Chen HY, D'Alton ME, Vintzileos AM. Electronic fetal monitoring in the United States: temporal trends and adverse perinatal outcomes. Obstet Gynecol 2013;121:927–33.
39. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311:806–14.
40. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998;22:39–47.
41. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549–55.